13 | AntigensIBA
05/2023
-
01/2017 |
13 | Chimeric Antigen ReceptorsIBA
04/2022
-
01/2017 |
13 | Peptides (Polypeptides)IBA
01/2020
-
01/2002 |
4 | Proteins (Proteins, Gene)FDA Link
09/2021
-
12/2007 |
4 | Radioisotopes (Radionuclides)IBA
01/2021
-
09/2009 |
4 | CytokinesIBA
05/2020
-
12/2017 |
4 | AcidsIBA
01/2018
-
11/2006 |
3 | GhrelinIBA
03/2021
-
04/2012 |
3 | Cetuximab (Erbitux)FDA Link
01/2021
-
02/2014 |
3 | EpitopesIBA
01/2020
-
01/2018 |
3 | Melanocyte-Stimulating Hormones (MSH)IBA
01/2019
-
03/2016 |
3 | CatecholaminesIBA
10/2018
-
11/2014 |
3 | Chelating AgentsIBA
10/2018
-
01/2014 |
3 | Diphosphonates (Bisphosphonates)IBA
05/2017
-
08/2013 |
3 | Bombesin Receptors (Bombesin Receptor)IBA
11/2013
-
02/2009 |
2 | Interleukin-2 (IL2)IBA
04/2024
-
01/2021 |
2 | Bispecific AntibodiesIBA
09/2021
-
01/2017 |
2 | CopperIBA
09/2021
-
05/2020 |
2 | Ghrelin ReceptorsIBA
03/2021
-
05/2015 |
2 | Caspase 3 (Caspase-3)IBA
01/2021
-
12/2020 |
2 | DNA (Deoxyribonucleic Acid)IBA
12/2020
-
01/2017 |
2 | Type 1 Melanocortin ReceptorIBA
01/2019
-
03/2016 |
2 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
10/2018
-
07/2017 |
2 | LuciferasesIBA
10/2018
-
11/2017 |
2 | Somatostatin Receptors (Somatostatin Receptor)IBA
10/2018
-
01/2016 |
2 | NormetanephrineIBA
10/2018
-
11/2014 |
2 | Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2018
-
11/2014 |
2 | 3-methoxytyramine (methoxytyramine)IBA
10/2018
-
11/2014 |
2 | Dopamine (Intropin)FDA LinkGeneric
10/2018
-
11/2014 |
2 | ErbB Receptors (EGF Receptor)IBA
10/2018
-
11/2017 |
2 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
10/2018
-
01/2017 |
2 | Lysine (L-Lysine)FDA Link
01/2018
-
11/2017 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
07/2017
-
01/2016 |
2 | BombesinIBA
01/2014
-
11/2013 |
2 | LigandsIBA
08/2013
-
11/2006 |
2 | Phosphotransferases (Kinase)IBA
12/2012
-
11/2012 |
2 | PhosphopeptidesIBA
11/2012
-
08/2011 |
2 | Molecular Probes (Molecular Probe)IBA
08/2011
-
02/2010 |
2 | Amino AcidsFDA Link
12/2007
-
12/2004 |
2 | Messenger RNA (mRNA)IBA
12/2007
-
08/2007 |
2 | Neurotensin Receptors (Neurotensin Receptor)IBA
09/2006
-
01/2002 |
1 | Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
04/2024 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
05/2023 |
1 | Hormones (Hormone)IBA
05/2023 |
1 | Pentetic Acid (DTPA)FDA LinkGeneric
05/2023 |
1 | Neoplasm Antigens (Tumor Antigens)IBA
09/2021 |
1 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2021 |
1 | IronIBA
09/2021 |
1 | IonsIBA
09/2021 |
1 | Chemotactic FactorsIBA
01/2021 |
1 | Matrix Metalloproteinases (MMPs)IBA
01/2021 |
1 | Complement System Proteins (Complement)IBA
01/2021 |
1 | neocuproineIBA
05/2020 |
1 | Liposomes (Liposome)IBA
05/2020 |
1 | CarbohydratesIBA
05/2020 |
1 | Therapeutic UsesIBA
01/2020 |
1 | Growth Factor ReceptorsIBA
01/2020 |
1 | Artificial ReceptorsIBA
01/2020 |
1 | PSMA-11IBA
01/2019 |
1 | LipopolysaccharidesIBA
12/2018 |
1 | thiocyanateIBA
10/2018 |
1 | MetanephrineIBA
10/2018 |
1 | Epinephrine (Adrenaline)FDA LinkGeneric
10/2018 |
1 | Alanine (L-Alanine)FDA Link
10/2018 |
1 | CarbonIBA
05/2018 |
1 | SiliconIBA
05/2018 |
1 | Antineoplastic Agents (Antineoplastics)IBA
03/2018 |
1 | 1'- benzyl- 3- (2- fluoroethyl)- 3H- spiro((2)benzofuran- 1,4'- piperidine)IBA
03/2018 |
1 | AminopropionitrileIBA
01/2018 |